Recap: ChromaDex Q4 Earnings


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Shares of ChromaDex (NASDAQ:CDXC) fell in after-market trading after the company reported Q4 results.

Quarterly Results

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Earnings per share were up 9.09% over the past year to ($0.10), which missed the estimate of ($0.09).

Revenue of $15,445,000 rose by 18.00% year over year, which beat the estimate of $15,360,000.

Guidance

ChromaDex Sees FY21 Sales Growth 'Steady' In Ecommerce Unit, Gross Margin Improvement To Be Slightly Better Than 60%

Conference Call Details


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


Date: Mar 10, 2021

Time: 04:30 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.google.com%2F&eventid=2947506&sessionid=1&key=BA28949A5DD50002B91BA32E315B1CC9®Tag=&V2=false&sourcepage=register

Technicals

Company's 52-week high was at $23.66

Company's 52-week low was at $2.50

Price action over last quarter: Up 127.37%

Company Description

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: EarningsBZI-Recaps